ZEALAND PHARMA A S's ticker is ZEAL and the CUSIP is 98920Y304. A total of 13 filers reported holding ZEALAND PHARMA A S in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -50.0% | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 100 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | +200.0% | 100 | +33.3% | 0.00% | – |
| Q3 2017 | $1,000 | – | 75 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 48,957 | $631,000 | 0.10% |
| GOLDMAN SACHS GROUP INC | 500,916 | $6,517,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 220,523 | $2,869,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 100 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| US BANCORP \DE\ | 509 | $7,000 | 0.00% |
| CREDIT SUISSE AG/ | 285 | $4,000 | 0.00% |
| MORGAN STANLEY | 6,705 | $87,000 | 0.00% |
| UBS Group AG | 351 | $4,000 | 0.00% |
| JANE STREET GROUP, LLC | 23,976 | $312,000 | 0.00% |